Skip to content
Seqlense EUR-Lex

2011/91/EU: Commission Decision of 10 February 2011 authorising a laboratory in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2011) 656) Text with EEA relevance

CELEX
32011D0091
Document type
DEC_ENTSCHEID
Sector
Legislation
Date of document
2011-02-10
In force since
2011-02-11
Status
In force

Text

Article-level text, parsed from the formex manifestation.

Article 1

In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratory is authorised to perform the serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets: Komipharm International Co. Ltd 1236-6 Jeoungwang-dong 420-450 Siheung-si, Gyeonggi-do South Korea

Article 2

This Decision shall apply from 1 March 2011.

Article 3

This Decision is addressed to the Member States.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions